WhatsApp
backNews Article

Gland Pharma Releases Audio Recording of Q2 and H1 FY27 Earnings Call

Earnings discussion held on November 6, 2026, audio webcast accessible via company website

Gland Pharma Limited announced the audio recording of its earnings call for the quarter and half year ended September 30, 2026, has been made available on its official website for investor access.

06 Nov 2026|GLAND+0.35%
Gland Pharma LimitedGLANDEarnings Call Transcript

Gland Pharma Limited

Earnings Call Transcript

Gland Pharma Limited has uploaded the audio recording of its earnings call for the quarter and half year ended September 30, 2026, enabling investors to review the discussion held on November 6, 2026.

The earnings call took place on November 6, 2026, at 18:30 IST, focusing on the company’s financial performance and operational updates for Q2 and H1 of fiscal year 2027.

Investors and stakeholders can access the audio recording of this call through a direct weblink on Gland Pharma’s official website, facilitating transparent communication.

This release comes in continuation of prior disclosures made by the company dated October 21, 2026, reflecting ongoing investor engagement efforts.

Highlights

  • Earnings call for Q2 and H1 FY27 held on November 6, 2026, at 18:30 IST.
  • Audio recording is publicly available at https://glandpharma.com/images/Q2_FY27.mp3.
  • Filing complies with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
  • Provides investors detailed access to management discussion and performance insights.

Key Data Snapshot

Earnings Call Date and TimeNovember 6, 2026 at 18:30 IST
Reporting PeriodQuarter and Half Year ended September 30, 2026
Audio Recording URLhttps://glandpharma.com/images/Q2_FY27.mp3
Stock SymbolGLAND
ISININE068V01023

What happened

  • Gland Pharma conducted an earnings call discussing financials for Q2 and H1 FY27 on November 6, 2026.
  • The company made the audio recording of this call publicly available on its website for investor reference.

Regulatory and governance context

  • This disclosure follows requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • It supplements previous disclosures issued on October 21, 2026, offering continuity in investor communication.

More News on Earnings Call Transcript

View all

Latest corporate announcements and market updates in Earnings Call Transcript.

View all news
Gland Pharma Releases Audio Recording of Q2 and H1 FY27 | Stockk News